| dbo:abstract
|
- إدوارد س. تايلور (بالإنجليزية: Edward Curtis Taylor) هو كيميائي أمريكي، ولد في 3 أغسطس 1923 في سبرينغفيلد في الولايات المتحدة، وتوفي في 22 نوفمبر 2017 في سانت بول في الولايات المتحدة. (ar)
- Edward Curtis Taylor Jr. (* 3. August 1923 in Springfield, Massachusetts; † 22. November 2017 in Saint Paul, Minnesota) war ein US-amerikanischer Chemiker und ehemaliger Professor an der Princeton University. Er befasste sich mit organischer Synthese und ist bekannt für die Entwicklung von Zytostatika. (de)
- Edward Curtis Taylor, Jr. (August 3, 1923 – November 22, 2017) was an American chemist who designed and synthesized the chemotherapy drug pemetrexed (brand name Alimta), an inhibitor of purine biosynthesis, with grant support from the U.S. National Cancer Institute, NIH. As of 2009, royalties for this drug from Eli Lilly & Co. paid to Princeton University were sufficient to completely finance a state-of-the-art 263,000-square-foot (24,400 m2) chemistry laboratory building. Taylor studied for his PhD from 1946 to 1949 at Cornell University with Professor Cornelius Cain. Taylor trained 187 PhD students. (en)
- Edward Curtis Taylor, Jr. (3 août 1923 - 22 novembre 2017) est un chimiste américain qui a conçu et synthétisé le médicament de chimiothérapie pemetrexed (nom de marque Alimta), un inhibiteur de la biosynthèse des purines, avec le soutien d'une subvention de l'US National Cancer Institute, NIH. (fr)
|
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 3215 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- إدوارد س. تايلور (بالإنجليزية: Edward Curtis Taylor) هو كيميائي أمريكي، ولد في 3 أغسطس 1923 في سبرينغفيلد في الولايات المتحدة، وتوفي في 22 نوفمبر 2017 في سانت بول في الولايات المتحدة. (ar)
- Edward Curtis Taylor Jr. (* 3. August 1923 in Springfield, Massachusetts; † 22. November 2017 in Saint Paul, Minnesota) war ein US-amerikanischer Chemiker und ehemaliger Professor an der Princeton University. Er befasste sich mit organischer Synthese und ist bekannt für die Entwicklung von Zytostatika. (de)
- Edward Curtis Taylor, Jr. (August 3, 1923 – November 22, 2017) was an American chemist who designed and synthesized the chemotherapy drug pemetrexed (brand name Alimta), an inhibitor of purine biosynthesis, with grant support from the U.S. National Cancer Institute, NIH. As of 2009, royalties for this drug from Eli Lilly & Co. paid to Princeton University were sufficient to completely finance a state-of-the-art 263,000-square-foot (24,400 m2) chemistry laboratory building. Taylor studied for his PhD from 1946 to 1949 at Cornell University with Professor Cornelius Cain. Taylor trained 187 PhD students. (en)
- Edward Curtis Taylor, Jr. (3 août 1923 - 22 novembre 2017) est un chimiste américain qui a conçu et synthétisé le médicament de chimiothérapie pemetrexed (nom de marque Alimta), un inhibiteur de la biosynthèse des purines, avec le soutien d'une subvention de l'US National Cancer Institute, NIH. (fr)
|
| rdfs:label
|
- إدوارد س. تايلور (ar)
- Edward C. Taylor (de)
- Edward C. Taylor (en)
- Edward C. Taylor (fr)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:doctoralAdvisor
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |